Primary Biliary Cholangitis Clinical Trials

122 clinical trials for Primary Biliary Cholangitis across international registries, including 32 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis — RECRUITING · PHASE3
• Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes — RECRUITING · PHASE3
• A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis — RECRUITING · PHASE3
• A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment — RECRUITING
• LEOPARD Training and Validation Data Collection Study — RECRUITING
• LEOPARD Prospective Validation Cohort 1 — RECRUITING
• A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA — RECRUITING · PHASE3
• A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction — RECRUITING · PHASE1
• Using Digital Health Technology to Monitor Patients With Primary Biliary Cholangitis (PBC) — RECRUITING
• Austrian PBC Registry — RECRUITING
• A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis — RECRUITING · PHASE2
• Biochemical Response and Clinical Outcomes in Patients With PBC — RECRUITING
• Fenofibrate in Primary Biliary Cholangitis: a Real World Study — RECRUITING · PHASE3
• Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis — RECRUITING · PHASE2
• Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study — RECRUITING · PHASE3
• Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis — RECRUITING · PHASE3
• FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy — RECRUITING · PHASE3
• A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics — RECRUITING · PHASE2
• Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP) — RECRUITING
• RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis — RECRUITING · NA
• PBC Long-term Outcomes Study — RECRUITING
• Swiss Primary Biliary Cholangitis Cohort Study — RECRUITING
• National Database on Primary Biliary Cholangitis — RECRUITING
• Fenofibrate in Patients With Primary Biliary Cholangitis (PBC) — RECRUITING · PHASE2
• Clinical Research of Tapering UDCA in PBC Patients With a Complete Response — RECRUITING · PHASE4
• Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai) — RECRUITING
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY TO EVALUATE THE EFFECT OF SELADELPAR ON CLINICAL OUTCOMES IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) AND COMPENSATED CIRRHOSIS — RECRUITING
• A PHASE III RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, TWO-ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELAFIBRANOR 80 MG ON LONG-TERM CLINICAL OUTCOMES IN ADULT PARTICIPANTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) — RECRUITING · PHASE3
• A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTICENTER 12-WEEK STUDY WITH A 52-WEEK EXTENSION TO EVALUATE THE EFFICACY AND SAFETY OF TWO DOSES OF K-808 (PEMAFIBRATE) IN SUBJECTS WITH PRIMARY BILIARY CHOLANGITIS WITH INADEQUATE RESPONSE TO URSODEOXYCHOLIC ACID. — RECRUITING · PHASE2
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VOLIXIBAT IN THE TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (VANTAGE) — RECRUITING
• Detection Program for Patients With Primary Biliary Cholangitis Lost in the System — RECRUITING
• ASSURE: AN OPEN LABEL LONG-TERM STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF SELADELPAR IN SUBJECTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) — RECRUITING
• A study evaluating the safety and efficacy of MBX-8025 in subjects with Primary Biliary Cholangitis (PBC) and an inadequate response to or intolerance to ursodeoxycholic acid (UDCA) — COMPLETED · PHASE2
• A multi-part, double blind study to assess safety, tolerability and efficacy of tropifexor (LJN452) in PBC patients — TERMINATED · PHASE2
• A Phase III Randomised, Parallel-Group, Double-Blind, Placebo-Controlled, Two-Arm Study to Evaluate the Efficacy and Safety of Elafibranor 80 mg on Long-Term Clinical Outcomes in Adult Participants With Primary Biliary Cholangitis (PBC) — TERMINATED · PHASE3
• A randomised, double-blind, placebo-controlled, two-part study to evaluate the pharmacokinetics, safety and tolerability, and preliminary efficacy of two dose levels of golexanolone in subjects with primary biliary cholangitis, fatigue, and cognitive dysfunction. — TERMINATED · PHASE2
• A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis — COMPLETED · PHASE1
• A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC) — ACTIVE_NOT_RECRUITING · PHASE3
• Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC) — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase IIIb Randomised, Parallel-Group, Double-Blind, Placebo-Controlled, Two-Arm Study to Evaluate the Effect of Elafibranor 80 mg on Normalisation of Alkaline Phosphatase in Adult Participants with Primary Biliary Cholangitis (PBC) and Inadequate Response or Intolerance to Ursodeoxycholic Acid — OTHER · PHASE3
• Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC — TERMINATED · PHASE2
• Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC — COMPLETED · PHASE2
• A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid. — COMPLETED · PHASE3
• The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching — NOT_YET_RECRUITING · PHASE2
• Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment. — ACTIVE_NOT_RECRUITING · PHASE2
• To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate — TERMINATED · PHASE3
• Patients With Primary Biliary Cholangitis(PBC) — ACTIVE_NOT_RECRUITING
• Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) — COMPLETED · PHASE3
• A PHASE III, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELAFIBRANOR IN ADULT PARTICIPANTS WITH PRIMARY SCLEROSING CHOLANGITIS — NOT_YET_RECRUITING · PHASE3
• Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy — NOT_YET_RECRUITING · PHASE3

Refine this search